Establishing the pharmaceutical quality of Chinese herbal medicine: A provisional BCS classification

Molecular Pharmaceutics

Volumn 10, Issue 5, 2013, Pages 1623-1643

  Fong, Sophia Y K ^a   Liu, Mary ^b   Wei, Hai ^c   Löbenberg, Raimar ^d   Kanfer, Isadore ^e   Lee, Vincent H L ^a   Amidon, Gordon L ^b   Zuo, Zhong ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b UNIVERSITY OF MICHIGAN   (United States)

^c SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^d UNIVERSITY OF ALBERTA   (Canada)

^e RHODES UNIVERSITY   (South Africa)

Author keywords

active marker compound; Biopharmaceutical Classification System; Chinese herbal medicine; dose number; permeability; solubility; traditional Chinese medicine

Indexed keywords

ASTRAGALOSIDE IV; BILOBALIDE; CALYCOSIN 7 GLUCOSIDE; CHINESE DRUG; EPHEDRINE; FERULIC ACID; FUFANG DANSHEN; GINKGO BILOBA EXTRACT; GINKGOLIDE; GINSENOSIDE RB 1; GINSENOSIDE RD; GINSENOSIDE RG 1; GLYCYRRHIZIC ACID; GONGXUENING; KAEMPFEROL; LEONARINE; LIQUIRITIN; PACONIFLORIN; PINGXIAO PIAN; POLYPHYLLIN IV; PSEUDOEPHEDRINE; QUERCITRIN; SALVIANOLIC ACID; SCUTELLARIN; SHEXIANG WAN; SHUANGHUANGLIAN; SYRINGIN; TANSHINONE IIA; UNCLASSIFIED DRUG; UNINDEXED DRUG; XUESHUAN XINMAINING; HERBACEOUS AGENT;

ANALGESIC ACTIVITY; ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CHINA; CHINESE MEDICINE; DRUG PENETRATION; DRUG SOLUBILITY; HEART PROTECTION; IN VITRO STUDY; LIVER PROTECTION; MEDICAL LITERATURE; NEUROPROTECTION; PATENT; PRIORITY JOURNAL; CLASSIFICATION; HUMAN; PERMEABILITY; QUALITY CONTROL; SOLUBILITY; STANDARDS; THERAPEUTIC EQUIVALENCE;

CHINA; DRUGS, CHINESE HERBAL; HUMANS; PERMEABILITY; QUALITY CONTROL; SOLUBILITY; THERAPEUTIC EQUIVALENCY;

EID: 84877270519     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp300502m     Document Type: Article

References (88)

1. Chen, F. P.; Chen, T. J.; Kung, Y. Y.; Chen, Y. C.; Chou, L. F.; Chen, F. J.; Hwang, S. J. Use Frequency of Traditional Chinese Medicine in Taiwan BMC Health Serv. Res. 2007, 7, 26
2. Cassidy, C. M. Chinese Medicine Users in the United States. Part I: Utilization, Satisfaction, Medical Plurality J. Altern. Complement. Med. 1998, 4, 17-27
3. Ernst, E.; White, A. The BBC Survey of Complementary Medicine Use in the UK Complement. Ther. Med. 2000, 8, 32-36
4. MacLennan, A. H.; Wilson, D. H.; Taylor, A. W. The Escalating Cost and Prevalence of Alternative Medicine Prev. Med. 2002, 35, 166-173
5. Molassiotis, A.; Fernadez-Ortega, P.; Pud, D.; Ozden, G.; Scott, J. A.; Panteli, V.; Margulies, A.; Browall, M.; Magri, M.; Selvekerova, S.; Madsen, E.; Milovics, L.; Bruyns, I.; Gudmundsdottir, G.; Hummerston, S.; Ahmad, A. M. A.; Platin, N.; Kearney, N.; Patiraki, E. Use of Complementary and Alternative Medicine in Cancer Patients: a European Survey Ann. Oncol. 2005, 16, 655-663
6. Li, S.; Han, Q.; Qiao, C.; Song, J.; Cheng, C. L.; Xu, H. Chemical Markers for the Quality Control of Herbal Medicines: an Overview Chin. Med. 2008, 3, 7
7. Dressman, J. B.; Amidon, G. L.; Reppas, C.; Shah, V. P. Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Immediate Release Dosage Forms Pharm. Res. 1998, 15, 11-22
8. Amidon, G. L.; Lennernäs, H.; Shah, V. P.; Crison, J. R. A Theoretical Basis for a Biopharmaceutic Drug Classification: the Correlation of In Vitro Drug Product Dissolution and In Vivo Bioavailability Pharm. Res. 1995, 12, 413-420
9. FDA Guidance for Industry. Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System; Federal Food and Drug Administration: Washington, DC, 2000.
10. Guideline on the Investigation of Bioequivalence; European Medicines Agency (EMEA), Committee for Medicinal Products for Human Use (CHMP): London, UK, 2008; p 29.
11. Kasim, N. A.; Whitehouse, M.; Ramachandran, C.; Bermejo, M.; Lennernäs, H.; Hussain, A. S.; Junginger, H. E.; Stavchansky, S. A.; Midha, K. K.; Shah, V. P.; Amidon, G. L.Molecular Properties of WHO Essential Drugs and Provisional Biopharmaceutical Classification Mol. Pharmaceutics 2004, 1, 85-96
12. Takagi, T.; Ramachandran, C.; Bermejo, M.; Yamashita, S.; Yu, L. X.; Amidon, G. L. A Provisional Biopharmaceutical Classification of the Top 200 Oral Drug Products in the United States, Great Britain, Spain, and Japan Mol. Pharmaceutics 2006, 3, 631-643
13. Shawahna, R.; Rahman, N. Evaluation of the Use of Partition Coefficients and Molecular Surface Properties as Predictors of Drug Absorption: a Provisional Biopharmaceutical Classification of the List of National Essential Medicines of Pakistan DARU J. Pharm. Sci. 2011, 19, 83-99
14. Waldmann, S.; Almukainzi, M.; Chacra, N.; Amidon, G. L.; Lee, B. J.; Feng, J.; Kanfer, I.; Zuo, Z.; Bolger, M.; Löbenberg, R. Provisional Biopharmaceutical Classification of Some Common Herbs Used in Western Medicine Mol. Pharmaceutics 2012, 9, 815-822
15. De Smet, P. A. Herbal Medicine in Europe-Relaxing Regulatory Standards N. Engl. J. Med. 2005, 352, 1176-1178
16. Health Canada, Natural Health Products Directorate. From http://www.hc-sc.gc.ca/dhp-mps/prodnatur/index-eng.php (accessed on Sep 27, 2011).
17. Although, F., Regulatory Situation of Herbal Medicines A Worldwide Review. World Health Organization, 1998. From http://apps.who.int.medicinedocs/ en/d/Jwhozip57e/ (accessed on Oct 10, 2011).
18. Drug Administration Law of the People's Republic of China. State Food and Drug Administration, P. R. China. From http://former.sfda.gov.cn/cmsweb/ webportal/-W45649037/A48335975.html (accessed on Oct 10, 2011).
19. Li, G. Q.; Duke, C. C.; Roufogalis, B. D. The Quality and Safety of Traditional Chinese Medicines Aust. Prescr. 2003, 26, 128-130
20. Pharmacopoeia of the People's Republic of China, Chinese ed.; The Pharmacopoeia Commission of the People's Republic of China; China Medical Science and Technology Press: Beijing, China, 2010; Vol. 1.
21. Pharmacopoeia of the People's Republic of China, Chinese ed.; The Pharmacopoeia Commission of the People's Republic of China; People's Medical Publishing House, 2005; Vol. 1.
22. Dharmananda, S. An Introduction to Chinese Herbs. 1996. From http://www.itmonline.org/arts/herbintro.htm (accessed on Sep 27, 2011).
23. Bhal, S. K. LogP-Making Sense of the Value. Advanced Chemistry Development Inc. (ACD/Labs). From http://www.acdlabs.com/resources/ knowledgebase/app-notes/-physchem/making-sense.php (accessed on Sep 27, 2011).
24. Bhal, S. K.; Kassam, K.; Peirson, I. G.; Pearl, G. M. The Rule of Five Revisited: Applying Log D in Place of Log P in Drug-Likeness Filters Mol. Pharmaceutics 2007, 4, 556-560
25. Grès, M.-C.; Julian, B.; Bourrié, M.; Meunier, V.; Roques, C.; Berger, M.; Boulenc, X.; Berger, Y.; Fabre, G. Correlation Between Oral Drug Absorption in Humans, and Apparent Drug Permeability in TC-7 Cells, A Human Epithelial Intestinal Cell Line: Comparison with the Parental Caco-2 Cell Line Pharm. Res. 1998, 15, 726-733
26. Yazdanian, M.; Glynn, S. L.; Wright, J. L.; Hawi, A. Correlating Partitioning and Caco-2 Cell Permeability of Structurally Diverse Small Molecular Weight Compounds Pharm. Res. 1998, 15, 1490-1494
27. Pade, V.; Stavchansky, S. Link Between Drug Absorption Solubility and Permeability Measurements in Caco-2 Cells J. Pharm. Sci. 1998, 87, 1604-1607
28. Hubatsch, I.; Ragnarsson, E. G.; Artursson, P. Determination of Drug Permeability and Prediction of Drug Absorption in Caco-2 Monolayers Nat. Protoc. 2007, 2, 2111-2119
29. Olukoga, A.; Donaldson, D. Liquorice and Its Health Implications J. R. Soc. Promot. Health. 2000, 120, 83-89
30. Gao, Q.; Li, J.; Cheung, J. K.; Duan, J.; Ding, A.; Cheung, A. W.; Zhao, K.; Li, W. Z.; Dong, T. T.; Tsim, K. W. Verification of the Formulation and Efficacy of Danggui Buxue Tang (A Decoction of Radix Astragali and Radix Angelicae Sinensis): an Exemplifying Systematic Approach to Revealing the Complexity of Chinese Herbal Medicine Formulae Chin. Med. 2007, 2, 12
31. Luszczki, J. J.; Zuchora, M.; Sawicka, K. M.; Kozinska, J.; Czuczwar, S. J. Acute Exposure to Caffeine Decreases the Anticonvulsant Action of Ethosuximide, But Not That of Clonazepam, Phenobarbital and Valproate Against Pentetrazole-Induced Seizures in Mice Pharmacol. Rep. 2006, 58, 652-659
32. Xu, L. H.; Huang, F.; Chen, T.; Wu, J. Anti-Virus Constituents in Radix Isatidis Chin. J. Nat. Med. 2005, 3, 359-360
33. Hayashi, K.; Imanishi, N.; Kashiwayama, Y.; Kawano, A.; Terasawa, K.; Shimada, Y.; Ochiai, H. Inhibitory Effect of Cinnamaldehyde, Derived from Cinnamomi Cortex, on the Growth of Influenza A/PR/8 Virus In Vitro and In Vivo Antiviral Res. 2007, 74, 1-8
34. Bae, K. H.; Ji, J. M.; Park, K. L. The Antibacterial Component from Cinnamomi Cortex Against a Cariogenic Bacterium Streptococcus mutans OMZ 176 Arch. Pharmacal Res. 1992, 15, 239-241
35. Amidon, G. L. In A New Era in BA/BE World, International Symposium on BA/BE of Oral Drug Products, Kobe, Japan, 2011.
36. Kim, J. S.; Mitchell, S.; Kijek, P.; Tsume, Y.; Hilfinger, J.; Amidon, G. L. The Suitability of an In Situ Perfusion Model for Permeability Determinations: Utility for BCS Class I Biowaiver Requests Mol. Pharmaceutics 2006, 3, 686-694
37. Winiwarter, S.; Bonham, N. M.; Ax, F.; Hallberg, A.; Lennernas, H.; Karlen, A. Correlation of Human Jejunal Permeability (In Vivo) of Drugs with Experimentally and Theoretically Derived Parameters. A Multivariate Data Analysis Approach J. Med. Chem. 1998, 41, 4939-4949
38. Linnankoski, J.; Makela, J. M.; Ranta, V.-P.; Urtti, A.; Yliperttula, M. Computational Prediction of Oral Drug Absorption Based on Absorption Rate Constants in Humans J. Med. Chem. 2006, 49, 3674-3681
39. Benet, L. Z.; Larregieu, C. A. The FDA Should Eliminate the Ambiguities in the Current BCS Biowaiver Guidance and Make Public the Drugs for Which BCS Biowaivers Have Been Granted Clin. Pharmacol. Ther. 2010, 88, 405-407
40. Pade, D.; Stavchansky, S. Selection of Bioavailability Markers for Herbal Extracts Based on In Silico Descriptors and Their Correlation to In Vitro Permeability. Mol. Pharmaceutics 5, 665-671.
41. Xie, Y.; Ma, Y. M.; Wang, C. H.; Tao, J. S. Overview and Consideration on Improving Oral Bioavailability of Traditional Chinese Medicine Preparation J. Int. Pharm. Res. 2011, 38, 195-200
42. Zhu, J. T.; Choi, R. C.; Li, J.; Xie, H. Q.; Bi, C. W.; Cheung, A. W.; Dong, T. T.; Jiang, Z. Y.; Chen, J. J.; Tsim, K. W. Estrogenic and Neuroprotective Properties of Scutellarin from Erigeron breviscapus: a Drug Against Postmenopausal Symptoms and Alzheimer's Disease Planta Med. 2009, 75, 1489-1493
43. Camuesco, D.; Comalada, M.; Rodriguez-Cabezas, M. E.; Nieto, A.; Lorente, M. D.; Concha, A.; Zarzuelo, A.; Galvez, J. The Intestinal Anti-inflammatory Effect of Quercitrin is Associated with an Inhibition in iNOS Expression Br. J. Pharmacol. 2004, 143, 908-918
44. Liu, X. H.; Pan, L. L.; Gong, Q. H.; Zhu, Y. Z. Antiapoptotic Effect of Novel Compound from Herba leonuri-Leonurine (SCM-198): a Mechanism Through Inhibition of Mitochondria Dysfunction in H9c2 Cells Curr. Pharm. Biotechnol. 2010, 11, 895-905
45. Li, X.; Yuan, F. L.; Zhao, Y. Q.; Chen, F. H.; Lu, W. G.; Li, C. W.; Li, J. P. Effects of Leonurine Hydrochloride on Medically Induced Incomplete Abortion in Early Pregnancy Rats Eur. J. Obstet. Gynecol. Reprod. Biol. 2011, 159, 375-380
46. Asl, M. N.; Hosseinzadeh, H. Review of Pharmacological Effects of Glycyrrhiza sp. and Its Bioactive Compounds Phytother. Res. 2008, 22, 709-724
47. Roth, R. P.; Cantekin, E. I.; Bluestone, C. D.; Welch, R. M.; Cho, Y. W. Nasal Decongestant Activity of Pseudoephedrine Ann. Otol. Rhinol. Laryngol. 1977, 86, 235-242
48. Silver, H. M.; Ohsaki, Y. The Effects of Pseudoephedrine in Brochospastic Subjects Curr. Ther. Res. Clin. Exp. 1963, 5, 1-6
49. Lin, C. C.; Hsieh, S. J.; Hsu, S. L.; Chang, C. M. Hot Pressurized Water Extraction of Syringin from Acanthopanax senticosus and In Vitro Activation on Rat-Blood Macrophages Biochem. Eng. J. 2007, 37, 117-124
50. Navarrete, A.; Arrieta, J.; Terrones, L.; Abou-Gazar, H.; Calis, I. Gastroprotective Effect of Astragaloside IV: Role of Prostaglandins, Sulfhydryls and Nitric Oxide J. Pharm. Pharmacol. 2005, 57, 1059-64
51. Wang, S.; Li, J.; Huang, H.; Gao, W.; Zhuang, C.; Li, B.; Zhou, P.; Kong, D. Anti-Hepatitis B Virus Activities of Astragaloside IV Isolated from Radix Astragali Biol. Pharm. Bull. 2009, 32, 132-135
52. Tang, D.; He, B.; Zheng, Z. G.; Wang, R. S.; Gu, F.; Duan, T. T.; Cheng, H. Q.; Zhu, Q. Inhibitory Effects of Two Major Isoflavonoids in Radix Astragali on High Glucose-Induced Mesangial Cells Proliferation and AGEs-Induced Endothelial Cells Apoptosis Planta Med. 2011, 77, 729-732
53. Ohta, H.; Matsumoto, K.; Shimizu, M.; Watanabe, H. Paeoniflorin Attenuates Learning Impairment of Aged Rats in Operant Brightness Discrimination Task Pharmacol., Biochem. Behav. 1994, 49, 213-217
54. Liu, D. Z.; Zhu, J.; Jin, D. Z.; Zhang, L. M.; Ji, X. Q.; Ye, Y.; Tang, C. P.; Zhu, X. Z. Behavioral Recovery Following Sub-Chronic Paeoniflorin Administration in the Striatal 6-OHDA Lesion Rodent Model of Parkinson's Disease J. Ethnopharmacol. 2007, 112, 327-332
55. Yu, H. Y.; Mu, D. G.; Chen, J.; Yin, W. Suppressive Effects of Intrathecal Paeoniflorin on Bee Venom-Induced Pain-Related Behaviors and Spinal Neuronal Activation Pharmacology 2011, 88, 159-166
56. Zhang, X. J.; Li, Z.; Leung, W. M.; Liu, L.; Xu, H. X.; Bian, Z. X. The Analgesic Effect of Paeoniflorin on Neonatal Maternal Separation-Induced Visceral Hyperalgesia in Rats J. Pain 2008, 9, 497-505
57. Sun, D.; Shen, M.; Li, J.; Li, W.; Zhang, Y.; Zhao, L.; Zhang, Z.; Yuan, Y.; Wang, H.; Cao, F. Cardioprotective Effects of Tanshinone IIA Pretreatment via Kinin B2 Receptor-Akt-GSK-3beta Dependent Pathway in Experimental Diabetic Cardiomyopathy Cardiovasc. Diabetol. 2011, 10, 4
58. Liu, J. Q.; Lee, T. F.; Miedzyblocki, M.; Chan, G. C.; Bigam, D. L.; Cheung, P. Y. Effects of Tanshinone IIA, a Major Component of Salvia miltiorrhiza, on Platelet Aggregation in Healthy Newborn Piglets J. Ethnopharmacol. 2011, 137, 44-49
59. He, H. B.; Yang, X. Z.; Shi, M. Q.; Zeng, X. W.; Wu, L. M.; Li, L. D. Comparison of Cardioprotective Effects of Salvianolic acid B and Benazepril on Large Myocardial Infarction in Rats Pharmacol. Rep. 2008, 60, 369-381
60. Yin, Z. Z.; Zhang, L. Y.; Xu, L. N. The Effect of Dang-Gui (Angelica sinensis) and its Ingredient Ferulic Acid on Rat Platelet Aggregation and Release of 5-HT Yaoxue Xuebao 1980, 15, 321-326
61. Wang, X. H.; Yin, Y. Q.; Sui, C. G.; Meng, F. D.; Ma, P.; Jiang, Y. H. Inhibitory Effect of Cantharidin on Proliferation of A549 Cells Chin. J. Cancer Res. 2007, 19, 283-286
62. Li, W.; Xie, L.; Chen, Z.; Zhu, Y.; Sun, Y.; Miao, Y.; Xu, Z.; Han, X. Cantharidin, a Potent and Selective PP2A Inhibitor, Induces an Oxidative Stress-Independent Growth Inhibition of Pancreatic Cancer Cells Through G2/M Cell-Cycle Arrest and Apoptosis Cancer Sci. 2010, 101, 1226-1233
63. Tian, Y.; Zheng, L. H.; Xu, Z. Y.; Sun, L. Q.; Gao, C. K.; Zheng, Q. Z.; Zhang, Z. H.; Shu, Y. Clinical and Pharmacological Study of the Hemostatic Action of Rhizoma paridis by Contraction of Uterus J. Trad. Chin. Med. 1986, 6, 178-182
64. Hen, J.; Lee, W.; Gu, Y.; Tong, Y.; Fung, P. C.; Tong, L. Ginkgo biloba Extract (EGb761) Inhibits Mitochondria-Dependent Caspase Pathway and Prevents Apoptosis in Hypoxia-Reoxygenated Cardiomyocytes Chin. Med. 2011, 6, 8
65. Smith, P. F.; Maclennan, K.; Darlington, C. L. The Neuroprotective Properties of the Ginkgo biloba Leaf: a Review of the Possible Relationship to Platelet-Activating Factor (PAF) J. Ethnopharmacol. 1996, 50, 131-139
66. Sun, R.; Zhang, Z. P.; Huang, W.; Lv, L.; Ren, H. Y. Protective Effects of Muskone on Rats with Complete Cerebral Ischemia Trad. Chin. Drug Res. Clin. Pharmacol. 2009, 3, 197-200
67. Zhang, S.; Song, Y. Q.; Ju, C. X.; Liu, Z. R.; Yue, W. Comparative Study of Survival Effects of Moschus and Muscone on Rat Retinal Neurons In Vitro Nat. Prod. Res. Dev. 2007, 19, 415-419
68. Chan, R. Y..; Chen, W. F.; Dong, A.; Guo, D.; Wong, M. S. Estrogen-Like Activity of Ginsenoside Rg1 Derived from Panax notoginseng J. Clin. Endocrinol. Metab. 2002, 87, 3691-3695
69. Li, S. H.; Chu, Y. Anti-inflammatory Effects of Total Saponins of Panax notoginseng Zhongguo Yao Li Xue Bao 1999, 20, 551-554
70. Shi, Q.; Hao, Q.; Bouissac, J.; Lu, Y.; Tian, S.; Luu, B. Ginsenoside-Rd from Panax notoginseng Ehances Astrocyte Differentiation from Neural Stem Cells Life Sci. 2005, 76, 983-995
71. Deng, X. K.; Yin, W.; Li, W. D.; Yin, F. Z.; Lu, X. Y.; Zhang, X. C.; Hua, Z. C.; Cai, B. C. The Anti-tumor Effects of Alkaloids from the Seeds of Strychnos nux-vomica on HepG2 Cells and its Possible Mechanism J. Ethnopharmacol. 2006, 106, 179-186
72. Shen, Y. C.; Chiou, W. F.; Chou, Y. C.; Chen, C. F. Mechanisms in Mediating the Anti-inflammatory Effects of Baicalin and Baicalein in Human Leukocytes Eur. J. Pharmacol. 2003, 465, 171-181
73. Liu, C. G.; Zhang, T. H.; Ding, R. G.; Zhao, J.; Huang, M. A Study on the Anti-inflammatory Effect of Bilirubin and Cholic Acid Analogs Pharm. J. Chin. People's Liberation Army 2008, 24, 479-481
74. Zheng, X.; Yang, D.; Liu, X.; Wang, N.; Li, B.; Cao, H.; Lu, Y.; Wei, G.; Zhou, H.; Zheng, J. Identification of a New Anti-LPS Agent, Geniposide, from Gardenia jasminoides Ellis, and its Ability of Direct Binding and Neutralization of Lipopolysaccharide In Vitro and In Vivo Int. Immunopharmacol. 2010, 10, 1209-1219
75. Lu, B. Q. Studies on Pharmacological Constituents of Shuanghuanglian Powder Injection. PhD Thesis. First Military Medical University, Guangzhou, China, 2007.
76. Stanely Mainzen Prince, P.; Karthick, M. Preventive Effect of Rutin on Lipids, Lipoproteins, and ATPases in Normal and Isoproterenol-induced Myocardial Infarction in Rats J. Biochem. Mol. Toxicol. 2007, 21, 1-6
77. Yang, C. M.; Sui, D. Y.; Yu, X. F.; Qu, S. C. Protective Effect of Xueshuan Xinmaining Capsules on Experimental Myocardial Infraction in Rats Wujing Yixue 2005, 16, 352-354
78. Song, H. P.; Guan, R. F. Pharmacology and Clinical Usage of Allicin Chin. Comm. Doctor 2007, 24, 9-10
79. Ried, K.; Frank, O. R.; Stocks, N. P.; Fakler, P.; Sullivan, T. Effect of Garlic on Blood Pressure: a Systematic Review and Meta-Analysis BMC Cardiovasc. Disord. 2008, 8
80. Lin, F. L.; Wu, S. J.; Lee, S. C.; Ng, L. T. Antioxidant, Antioedema and Analgesic Activities of Andrographis paniculata Extracts and Their Active Constituent Andrographolide Phytother. Res. 2009, 23, 958-64
81. Shen, Y. C.; Chen, C. F.; Chiou, W. F. Andrographolide Prevents Oxygen Radical Production by Human Neutrophils: Possible Mechanism(s) Involved in its Anti-inflammatory Effect Br. J. Pharmacol. 2002, 135, 399-406
82. Varma, D. R.; Yue, T. L. Adrenoceptor Blocking Properties of Atropine-like Agents Anisodamine and Anisodine on Brain and Cardiovascular Tissues of Rats Br. J. Pharmacol. 1986, 87, 587-94
83. Cai, J. X. The Clinical Usage of Asiaticosid Strait Pharm. J. 2007, 19, 92-93
84. Kimura, Y.; Sumiyoshi, M.; Samukawa, K. I.; Satake, N.; Sakanaka, M. Facilitating Action of Asiaticoside at Low Doses on Burn Wound Repair and its Mechanism Eur. J. Pharmacol. 2008, 584, 415-423
85. Peng, Y.; Xu, S.; Chen, G.; Wang, L.; Feng, Y.; Wang, X. l-3-n-Butylphthalide Improves Cognitive Impairment Induced by Chronic Cerebral Hypoperfusion in Rats J. Pharmacol. Exp. Ther. 2007, 321, 902-910
86. Liu, X.; Liao, Q. D.; Cao, H. X.; Huang, J. J. Effect of Extract of Horse Chestnut Seeds(aescuven forte) on IL-6, IL-1β and TNF in Patients with Limb Trauma Zhongnan Yaoxue 2009, 7, 777-780
87. Ono, M.; Satoh, T. Pharmacological Studies on Lappaconitine: Antinociception and Inhibition of the Spinal Action of Substance P and Somatostatin Jpn. J. Pharmacol. 1991, 55, 523-530
88. Pei, Y. P.; Chen, J.; Li, W. L. Progress in Research and Application of Silymarin Med. Aromatic Plant Sci. Biotechnol. 2009, 3, 1-8